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ABSTRACT
Objective: The objective of the study was to evaluate the adverse drug reaction (ADR) related to commonly used antimicrobials in a tertiary care 
hospital.
Methods: A prospective spontaneous reporting study involving, active methods (pharmacist actively looking for suspected ADRs) and passive 
methods (stimulating prescribers to report suspected ADRs) was carried out in all departments of a tertiary care hospital, for 1 year. Patients of all 
age groups were included in the study. The data for the study were taken from case sheets, investigation reports of patients who had experienced an 
ADR, personal interviews with reporting persons or clinicians, personal interviews with patient or patient’s attendant, past history of medication use, 
which were generally obtained from, prescriptions from the past, reports of medical and surgical interventions, referral letters, ADR reporting forms. 
Collected data were then analyze for causality assessment by Naranjo’s scale and severity assessment by Hartwig and Siegel’s scale.
Result: During 1 year of study period, 75 ADRs related to antimicrobial were reported among 1354 patients who were given antibiotic for the 
treatment. The incidence rate of antibiotic was found to be 5.53%. The department that reported ADR was medicine (10.16%), ENT (4.6%), pediatric 
(8.12%), orthopedics (06.9%), surgery (06.9%), chest and tuberculosis (04.6%), obstetrics and gynecology (06.9%), dentistry (02.3%), and skin 
(10.16%). The most common ADRs were related to gastrointestinal tract; dermatological reactions were second in the list of antimicrobial drugs 
causing ADR. In this study, among antimicrobials, fluoroquinolones, and beta-lactam antibiotics were the most common drugs causing gastrointestinal 
and dermatological ADRs. There was no unknown ADR reported that may need to be further investigated through active monitoring. All patients 
recovered from ADRs without any complications. The causality was assessed by Naranjo’s scale and it revealed that out of 75 antibiotics related ADR 
48 (64%) were possible, 27 (36%) were probable, 3 (4.00%) were definate, and 0% were unlikely. According to the Hartwig and Siegel’s scale, most 
of ADR were mild 45 (60%) and moderate 30 (40%) in nature.
Conclusion: ADRs related to antimicrobials occurs frequently. Among antimicrobials, fluoroquinolones, and beta-lactam antibiotics were the most 
common drugs causing gastrointestinal and dermatological ADRs. The health-care system can promote the spontaneous reporting of antimicrobial 
ADR to pharmacovigilance center for ensuring safe drug use and patient care.
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INRODUCTION
Drugs are the most common medical interventions, primarily used 
to relieve sufferings. However, it has been recognized long ago that 
drug themselves can prove fatal, as the saying rightly goes “Drugs are 
double edged weapons.” Adverse reaction monitoring and reporting 
are very important in identifying the adverse reaction trends in local 
population [1]. In simple definition, adverse drug reaction (ADR) has 
been defined as any noxious, unintended, and undesired effect of a 
drug which occurs at a dose used in humans for prophylaxis, diagnosis, 
therapy, or modification of physiological functions [2]. ADRs result in 
diminished quality of life, increased physician visits, hospitalizations, 
and even death. There is a need to study ADRs and ADRs reporting to 
minimize the risk of medicines. Antimicrobial agents are frequently 
mentioned in studies of ADRs [3] because wide and indiscriminate use 
of antimicrobial agents has resulted in rise of ADR incidence. According 
to a study conducted by Novotny et al., the most troublesome classes of 
drugs contributing to ADRs were antibiotics followed antitumor agents; 
they are responsible for the recorded adverse effects in approximately 
16% and 15% of cases, respectively [4] The main aim of this study was 
to detect and analyze ADRs to antimicrobial drugs in a tertiary care 
hospital.
METHODS
A prospective spontaneous reporting study involving, active methods 
(pharmacist actively looking for suspected ADRs) and passive methods 
(stimulating prescribers to report suspected ADRs) was carried out 
in all departments of a tertiary care hospital, for 1 year. Patients of all 
age groups who developed ADRs of antibiotics were included in the 
study. The data for the study were taken from case sheets, investigation 
reports of patients who had experienced an ADR, personal interviews 
with reporting persons or clinicians, personal interviews with patient or 
patient’s attendant, past history of medication use, which were generally 
obtained from, prescriptions from the past, reports of medical and 
surgical interventions, referral letters, ADR reporting forms. They were 
asked to fill suspected ADR reporting form which elicited information 
about patient particulars such as name, age, gender, weight, date on 
which reaction started, date of recovery (if occur), details of reactions, 
suspected medications (generic and trade name), dose, frequency and 
route used, indications, other drugs taken concomitantly, and physician 
remarks (as mentioned in CDSCO’s ADR reporting forms). Collected 
data were then analyze for causality assessment by Naranjo’s scale and 
severity assessment by Hartwig and Siegel’s scale.
Severity assessment by modified Hartwig and Siegel severity 
assessment scale
The severity of the reaction was assessed using the modified Hartwig 
and Siegel severity assessment scale [5], and the severity is broadly 
categorized into “mild,” “moderate,” and “severe” for each ADR. The 
suspected ADR is “mild” when “an ADR occurs but requires no change in 
treatment with the suspected drug” or the ADR requires that treatment 
with the suspected drug be held, discontinued, or otherwise changed. 
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No antidote or other treatment requirement was required. No increase 
in length of stay (LOS). The suspected ADR is “moderate” when “the 
ADR requires treatment with the suspected drug be held, discontinued, 
or otherwise changed” and/or “an Antidote or other treatment was 
required. No increase in LOS” or “any level 3 ADR that increases LOS 
by at least 1 day,” or “the ADR was the reason for the admission.” 
The suspected ADR is “severe” when “Any level 4 ADR that requires 
intensive medical care or the adverse reaction caused permanent harm 
to the patient or the adverse reaction either directly or indirectly led to 
death of the patient.”
Causality assessment
The extent of relationship between suspected ADR and the drug therapy 
was assessed using the Naranjo’s algorithmic scale [6].
Score Interpretation of scores
Total score >9 Definite: The reaction, (1) followed a reasonable 
temporal sequence after a drug or in which a toxic 
drug level had been established in body fluids 
or tissues, (2) followed a recognized response 
to the suspected drug, and (3) was confirmed 
by improvement on withdrawing the drug and 
reappeared on re-exposure
Total score 5-8 Probable: The reaction, (1) followed a reasonable 
temporal sequence after a drug, (2) followed 
a recognized response to the suspected 
drug, (3) was confirmed by withdrawal but 
not by exposure to the drug, and (4) could 
not be reasonably explained by the known 
characteristics of the patient’s clinical state
Total score 1-4 Possible: The reaction, (1) followed a temporal 
sequence after a drug, (2) possibly followed a 
recognized pattern to the suspected drug, and 
(3) could be explained by characteristics of the 
patient’s disease
Total score ≤0 Doubtful: The reaction was likely related to 
factors other than a drug
RESULTS
During 1 year of study period, 75 ADRs related to antimicrobial were 
reported among 1354 patients who were given antibiotic for the 
treatment. The incidence rate of antibiotic was found to be 5.53%. The 
department that reported ADR was medicine (10.16%), ENT (4.6%), 
pediatric (10.16%), orthopedics (06.9%), surgery (06.9%), chest and 
tuberculosis (04.6%), obstetrics and gynecology (06.9%), dentistry 
(8.12%), and skin (02.3%). The most common ADRs were related to 
gastrointestinal tract; dermatological reactions were second in the 
list of antimicrobial drugs causing ADR. In the present study, among 
antimicrobials, fluoroquinolones, and beta-lactam antibiotics were the 
most common drugs causing gastrointestinal and dermatological ADRs 
as shown in Table 1. There was no unknown ADR reported that may 
need to be further investigated through active monitoring. All patients 
recovered from ADRs without any complications. The causality was 
assessed by Naranjo’s scale and it revealed that out of 75 antibiotic 
related ADR 48 (64%) were possible, 27 (36%) were probable, 
3 (4.00%) were definite, and 0% doubtful as shown in Table 2. 
According to the Hartwig and Siegel’s scale, most of ADR were mild 45 
(60%) and moderate 30 (40%) in nature.as shown in Table 2.
DISCUSSION
Antibiotics are used for treatment and prophylaxis of various infectious 
conditions and are considered as safer drugs when used rationally. 
However, like all other drugs, they also show some ADRs in various 
patient conditions. The study tried to find out antimicrobial-related 
ADR in a large and diverse population. In the studies carried out in 
Nigerian children antibiotics were the most accounted drug class 
in ADR occurrence [7]. This study showed an incidence of 5.53% for 
antimicrobial-related ADRs which is comparable to other studies Gallelli 
et al. 2002 [8]; most of the antibiotic ADRs were detected from general 
medicine and pediatrics departments. This may be due to an increased 
use of antibiotics in these departments for treatment and prophylaxis 
of various diseases. The documented antibiotic ADRs are mainly 
affecting the gold in-tube and skin, and this study also pointed out the 
same. The study of Benjamin et al. also found the predominance of 
the gastrointestinal system followed by the skin in ADR occurrence [9]. 
The study done by Hussain et al. 2010 also showed the predominance of 
cutaneous manifestations [10]; the beta-lactams and fluoroquinolones 
were the most used antibiotic class in the hospital, so the reported 
ADRs were also more in these drug classes. A study conducted by 
Stavreva et al. also revealed the predominance of beta-lactams [11]. 
The most of antimicrobial ADR were mild to moderate in nature which 
was comparable to previous study Jimmy 2008 [12]. The causality 
assessment of ADRs had been done using the Naranjo scale, in which 
no reactions were found to be doubtful, and the majority were possible 
with a less number of probable and definite reactions. Every single ADR 
case report is important and can make major difference [13] Often the 
ADR is not recognized and go unreported. The principle limitation of 
Table 1: Frequency of ADRs related to antimicrobials
Drug n (%)
LM Ab.P N, V, G An TD Con Pru Ras Jaun Numb VD Total ADR
Coamoxclav 8 (57) 6 (43) 14 (18.6)
Cefixime 5 (42) 7 (58) 12 (16.0)
Cefpodoximeproxetil 4 (67) 2 (33) 6 (8.0)
Ciprofloxacin 3 (60) 2 (40) 5 (6.6)
Ofloxacin 3 (75) 1 (25) 4 (5.3)
Norfloxacin 1 (16) 5 (83) 6 (8.0)
Cotrimoxazole 2 (40) 1 (20) 2 (40) 5 (7.0)
Azithromycin 1 (50) 1 (50) 2 (3.0)
Metronidazole 2 (28) 5 (71) 7 (9.8)
Nitrofurantoin 3 (100) 3 (4.0)
Terbinafine 2 (100) 2 (2.6)
Fluconazole 2 (100) 2 (2.6)
Amikacin 2 (66) 1 (33) 3 (4.0)
Isoniazid 1 (100) 1 (1.3)
Rifampin 1 (100) 1 (1.3)
Pyrazinamide 1 (100) 1 (1.3)
Ethambutol 1 (100) 1 (1.3)
LM: Loose motion, Ab.P: Abdominal pain, N, V, G: Nausea, Vomiting, Gastritis, An: Anorexia, TD: Taste disturbance, Con: Constipation, Pru: Pruritus, Ras: Rashes, 
Jaun: Jaundice, Numb: Numbness, VD: Visual disturbance
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ADR detection is lack of awareness of, what constitutes an ADR. Most 
of the ADRs are bought to medical attention by subjective reports and 
patients complaints [14].
CONCLUSION
Antibiotics are the most widely prescribed drug so it require more ADR 
monitoring. Hence, implementation of the spontaneous reporting of 
ADRs to antibiotics should be encouraged and periodic reporting to 
regional pharmacovigilance centers should be done to ensure patient 
safety.
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Table 2: Causality and severity assessment
Drug Route of administration ADRs Causality score Severity scale
Coamoxclav Oral LM Ras Probable 
Possible


















































Nitrofurantoin Oral N, V, G, Probable Moderate L3
Terbinafine Oral TD Possible Mild L1







Isoniazid Oral Numb Definate Moderate L3
Rifampin Oral Jaun Definate Moderate L3
Pyrazinamide Oral Jaun Probable Moderate L3
Ethambutol Oral VD Definate Moderate L3
LM: Loose motion, Ab.P: Abdominal pain, N, V, G: Nausea, Vomiting, Gastrities, An: Anorexia, TD: Taste disturbance, Con: Constipation, Pru: Pruritus, Ras: Rashes, 
Jaun: Jaundice, Numb: Numbness, VD: Visual disturbance, L1: The ADR require no change in the treatment with the suspected drug, L3: The ADR requires that the 
suspected drug is withheld, discontinued otherwise changed and/or an antidote or other treatment is required. There is no increase in length of stay
